The global celiac drugs market is present worth USD 703.54 million and is poised to amplify with a CAGR of 16.95% over 2023-2033, thereby amassing a valuation of USD 2462.1 million by end of the assessment timeframe. Celiac disease is referred to as a type of autoimmune disorder which gets trigged by the consumption of gluten based products. The ailment primarily causes inflammation which ends up damaging the lining of the small intestine.
Read More: https://wemarketresearch.com/r....eports/celiac-drugs-
Like
Comment
Share
